A Rare Quarterly Appearance by bluebird bio Inc.'s Management
bluebird bio (NASDAQ: BLUE) released third-quarter earnings complete with a conference call, which the biotech doesn't usually hold for quarterly results, but this quarter was different with earnings coinciding with the release of abstracts for the American Society of Hematology (ASH) meeting next month.
Metric
Q3 2017
Source: Fool.com
Bluebird Bio Inc. Stock
€0.64
0.650%
With 7 Buy predictions and 6 Sell predictions the community is currently undecided on Bluebird Bio Inc..
Based on the current price of 0.64 € the target price of 5 € shows a potential of 677.36% for Bluebird Bio Inc. which would more than double the current price.
